arrow
G

Galal Magdy

Mansoura National University
H指数:33
被引数:2,538

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Metal Complex-Based Fluorescent Probe for Sensitive Determination of Citric Acid in Food Samples via a Ligand-Exchange Reaction: An Innovative and Sustainable Approach

金属配合物基荧光探针通过配体交换反应对食品样品中柠檬酸进行敏感检测:一种创新且可持续的方法

2026-10-060
PRE
Spectrophotometric determination of cefepime and enmetazobactam in pharmaceutical formulations and human plasma using chemometric modeling, metaheuristic wavelength selection, and comprehensive sustainability assessment

基于化学计量学建模、元启发式波长选择和全面可持续性评估的光谱法测定头孢吡肟和恩美他唑巴坦在药物制剂和人体血浆中的含量

2026-08-120
OA
Rapid Microwave-Assisted Synthesis of Silver Nanoparticles as a Luminescent Nanosensor for Baloxavir Marboxil Determination in Pharmaceuticals and Human Plasma: Comprehensive Assessment of the Method's Sustainability

微波辅助快速合成银纳米粒子作为发光纳米传感器用于巴洛沙韦马波西尔在药品和人体血浆中的测定:方法可持续性的全面评估

2026-05-080
PRE
A novel room-temperature CQD fluorescent nanosensor for the first derivatization-free spectrofluorimetric determination of dalfampridine: application to biological fluids and content uniformity testing

一种新型室温CQD荧光纳米传感器,用于首次无衍生化的光谱荧光法测定达非姆品:在生物流体和含量均匀性测试中的应用

2026-03-170
OAAI
Sustainable UV–spectrophotometric analysis of meloxicam and Rizatriptan in newly FDA-approved tablets using Fedorov algorithm–optimized regression, learning, and MCR-ALS resolution-based models with MA and NQS assessment

使用Fedorov算法优化的回归、学习及基于MCR-ALS分辨率的模型,结合MA和NQS评估,对新近FDA批准的 tablets 中美洛昔康(meloxicam)和瑞扎曲坦(Rizatriptan)进行可持续的UV光谱分析。

2025-11-030
PRE
A Novel Highly Sensitive Derivatization-Free Spectrofluorimetric Approach for Analysis of the Antifungal Terconazole in Dosage Forms, Biological Fluids, and Environmental Water Samples: Assessment of Greenness and Blueness Profiles

一种新型高灵敏度、无需衍生化的光谱荧光法测定剂型、生物流体及环境水样中抗真菌药物Terconazole的方法:绿色和蓝色特征评估

2025-09-030
PRE